furazolidone has been researched along with Respiratory Tract Diseases in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
COSGROVE, AS | 1 |
van Cauwenberge, H | 1 |
2 other studies available for furazolidone and Respiratory Tract Diseases
Article | Year |
---|---|
Inhalation treatment of chronic respiratory disease in chickens: controlled field studies with furazolidone and dihydrostreptomycin dusts.
Topics: Animals; Chickens; Chronic Disease; Dihydrostreptomycin Sulfate; Disease; Dust; Furans; Furazolidone | 1958 |
[Current therapeutics in clinical medicine].
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cephalosporins; Endocrine Sys | 1969 |